CD40LG and COVID-19: Seroconversion levels of RBD-specific IgM and IgG antibodies were detected in the majority of COVID-19 respiratory samples (34/41, 83%) and patients (26/33, 79%) (Fig. 3e), suggesting the prominence of RBD-specific IgM and IgG in respiratory samples during acute COVID-19.